COMP <GO>
LCII vs PG // ENTERPRISE SCALE & MARKET CAP
LCI Industries (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: LCII 8
— PG 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PG
LAST: $98.98 (+0.01%) • MKT CAP: $2.41B
market-cap
$2.41B
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
market-cap
$372.21B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LCII VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LCII | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.80% | 51.20% | -27.40 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.60% | 25.40% | -14.80 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.6x | 16.2x | -6.60 | LCII | /valuation <GO> |
| Free Cash Flow Yield | 11.57% | 3.77% | +7.80 | LCII | /fcf-yield <GO> |
| Operating Margin | 6.80% | 24.30% | -17.50 | PG | /operating-margins <GO> |
| Net Profit Margin | 4.60% | 19.00% | -14.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 10.20% | 0.30% | +9.90 | LCII | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.74% | 2.65% | +2.09 | LCII | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.28 | 5.59 | -2.31 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | LCII | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.50% | +0.90 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.2 | 62.7 | +9.48 | LCII | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.87 | +0.28 | LCII | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.9x | 21.7x | -9.80 | LCII | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.41B | $372.21B | -$369.81B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LCII REV | PG REV | LCII GROSS % | PG GROSS % | LCII FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.12B | $84.28B | 23.8% | 51.2% | $278.3M | $14.04B |
| FY 2024 | $3.74B | $84.04B | 23.5% | 51.4% | $328.0M | $16.52B |
| FY 2023 | $3.78B | $82.01B | 44.0% | 44.0% | $356.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LCII // BETA 1.15
PG // BETA 0.87